Advanced Wound Care Market by Product (Dressings (Foam, Hydrocolloid, Film), NPWT, Debridement Devices, Biological Skin Substitutes, Topical Agents), Wound Type (Surgical, Traumatic, Ulcers, Burns), End User (Hospital, Homecare), Region - Global Forecast to 2030

1 INTRODUCTION 33 1.1 STUDY OBJECTIVES 33 1.2 MARKET DEFINITION 33 1.3 STUDY SCOPE 34 1.3.1 MARKETS COVERED AND REGIONAL SCOPE 34 1.3.2 INCLUSIONS AND EXCLUSIONS 35 1.3.3 YEARS CONSIDERED 36 1.4 CURRENCY CONSIDERED 36 1.5 STAKEHOLDERS 36 1.6 SUMMARY OF CHANGES 37 2 RESEARCH METHODOLOGY 38 2.1 RESEARCH DATA 38 2.1.1 SECONDARY DATA 38 2.1.1.1 Key data from secondary sources 39 2.1.2 PRIMARY DATA 40 2.1.2.1 Primary sources 40 2.1.2.2 Key industry insights 41 2.1.2.3 Key data from primary sources 41 2.1.2.4 Breakdown of primary interviews 42 2.2 MARKET SIZE ESTIMATION 43 2.2.1 BOTTOM-UP APPROACH 43 2.2.1.1 Approach 1: Company revenue estimation approach 43 2.2.1.2 Approach 2: Presentations of companies and primary interviews 43 2.2.1.3 Approach 3: Primary interviews 44 2.2.1.4 Growth forecast 44 2.2.1.5 CAGR projections 44 2.2.2 TOP-DOWN APPROACH 44 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 46 2.4 RESEARCH ASSUMPTIONS 47 2.4.1 STUDY-RELATED ASSUMPTIONS 47 2.4.2 PARAMETRIC ASSUMPTIONS 47 2.4.3 GROWTH RATE ASSUMPTIONS 47 2.5 RESEARCH LIMITATIONS 48 2.6 RISK ASSESSMENT 48 3 EXECUTIVE SUMMARY 49   4 PREMIUM INSIGHTS 53 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN ADVANCED WOUND CARE MARKET 53 4.2 ASIA PACIFIC: ADVANCED WOUND CARE MARKET SHARE, BY END USER AND COUNTRY 54 4.3 ADVANCED WOUND CARE MARKET, BY KEY COUNTRY 55 4.4 ADVANCED WOUND CARE MARKET, BY REGION, 2025 VS. 2030 55 5 MARKET OVERVIEW 56 5.1 INTRODUCTION 56 5.2 MARKET DYNAMICS 56 5.2.1 DRIVERS 57 5.2.1.1 Growing geriatric population 57 5.2.1.2 Increasing cases of traumatic injuries 58 5.2.1.3 Growing prevalence of chronic diseases 58 5.2.1.4 Rising incidence of burn injuries 59 5.2.1.5 Government initiatives and reimbursement policies 60 5.2.2 RESTRAINTS 61 5.2.2.1 High cost of advanced wound care products 61 5.2.2.2 Risks associated with use of advanced wound care products 61 5.2.3 OPPORTUNITIES 62 5.2.3.1 Growth opportunities in emerging economies 62 5.2.3.2 Technological advancement in wound care 63 5.2.4 CHALLENGES 63 5.2.4.1 Lack of trained healthcare professionals 63 5.2.4.2 Limited awareness in underdeveloped regions 64 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 64 5.4 PRICING ANALYSIS 65 5.4.1 AVERAGE SELLING PRICE TREND, BY PRODUCT 65 5.4.2 AVERAGE SELLING PRICE TREND, BY WOUND TYPE 65 5.4.3 AVERAGE SELLING PRICE TREND, BY REGION 66 5.5 VALUE CHAIN ANALYSIS 66 5.6 SUPPLY CHAIN ANALYSIS 68 5.7 ECOSYSTEM ANALYSIS 69 5.8 INVESTMENT AND FUNDING SCENARIO 70 5.9 TECHNOLOGY ANALYSIS 70 5.9.1 KEY TECHNOLOGIES 70 5.9.1.1 Negative pressure wound therapy 70 5.9.2 COMPLEMENTARY TECHNOLOGIES 71 5.9.2.1 Micropore particle technology 71 5.9.3 ADJACENT TECHNOLOGIES 71 5.9.3.1 Telemedicine and mobile health (MHealth) 71 5.10 PATENT ANALYSIS 72 5.11 TRADE ANALYSIS 73 5.11.1 IMPORT DATA (HS CODE 300510) 74 5.11.2 EXPORT DATA (HS CODE 300510) 74 5.12 KEY CONFERENCES AND EVENTS, 2025–2026 75 5.13 CASE STUDY ANALYSIS 76 5.13.1 CASE STUDY 1: COMPLEX WOUND HEALING WITH TOPICAL ADVANCED WOUND CARE 76 5.13.2 CASE STUDY 2: EVALUATION OF NEW HYDROCOLL HYDROCOLLOID DRESSING IN WOUND CARE 76 5.13.3 CASE STUDY 3: SUPPORTED SELF-MANAGEMENT OF HARD-TO-HEAL PRESSURE ULCERS USING A SIMPLE 3-STEP FRAMEWORK DEVELOPED BY COLOPLAST 77 5.14 REGULATORY LANDSCAPE 78 5.14.1 REGULATORY ANALYSIS 78 5.14.1.1 North America 78 5.14.1.1.1 US 78 5.14.1.1.2 Canada 78 5.14.1.2 Europe 78 5.14.1.2.1 Germany 79 5.14.1.2.2 UK 79 5.14.1.2.3 France 79 5.14.1.3 Asia Pacific 79 5.14.1.3.1 China 79 5.14.1.3.2 Japan 79 5.14.1.3.3 India 80 5.14.1.4 Latin America 80 5.14.1.5 Middle East 80 5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81 5.14.2.1 North America 81 5.14.2.2 Europe 81 5.14.2.3 Asia Pacific 81 5.14.2.4 Latin America 82 5.14.2.5 Rest of the World 82 5.15 PORTER’S FIVE FORCES ANALYSIS 83 5.15.1 BARGAINING POWER OF SUPPLIERS 84 5.15.2 BARGAINING POWER OF BUYERS 84 5.15.3 THREAT OF NEW ENTRANTS 84 5.15.4 THREAT OF SUBSTITUTES 84 5.15.5 INTENSITY OF COMPETITIVE RIVALRY 84 5.16 KEY STAKEHOLDERS AND BUYING CRITERIA 84 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 85 5.16.2 BUYING CRITERIA 85 5.17 IMPACT OF AI ON ADVANCED WOUND CARE MARKET 86 5.17.1 INTRODUCTION 86 5.17.2 MARKET POTENTIAL OF AI IN ADVANCED WOUND CARE MARKET 86 5.17.3 AI USE CASES 87 5.17.4 KEY COMPANIES IMPLEMENTING AI 87 5.17.5 FUTURE OF AI IN ADVANCED WOUND CARE MARKET 88 5.18 IMPACT OF US TARIFF REGULATION ON ADVANCED WOUND CARE MARKET 88 5.18.1 INTRODUCTION 88 5.18.2 KEY TARIFF RATES 89 5.18.3 PRICE IMPACT ANALYSIS 89 5.18.4 KEY IMPACTS ON COUNTRY/REGION 90 5.18.4.1 North America 90 5.18.4.2 Europe 90 5.18.4.3 Asia Pacific 90 5.18.5 IMPACT ON END-USE INDUSTRIES 90 5.18.5.1 Hospitals, ASCs, and wound care centers 91 6 ADVANCED WOUND CARE MARKET, BY PRODUCT 92 6.1 INTRODUCTION 93 6.2 DRESSINGS 93 6.2.1 FOAM DRESSINGS 96 6.2.1.1 Silicone dressings 100 6.2.1.1.1 Ability to expedite wound closure and reduce risk of maceration to drive market 100 6.2.1.2 Non-silicone dressings 102 6.2.1.2.1 Advantages such as scar removal and wound healing to drive demand 102 6.2.2 HYDROCOLLOID DRESSINGS 105 6.2.2.1 Ability to promote granulation and formation of new tissues in open wounds to boost adoption 105 6.2.3 FILM DRESSINGS 108 6.2.3.1 Non-absorbable nature of film dressings to limit adoption 108 6.2.4 ALGINATE DRESSINGS 110 6.2.4.1 Growing incidence of pressure and diabetic foot ulcers to fuel growth 110 6.2.5 HYDROGEL DRESSINGS 113 6.2.5.1 Ability to provide relief and cooling effect on skin to drive use of hydrogel dressings 113 6.2.6 COLLAGEN DRESSINGS 115 6.2.6.1 Favorable reimbursement scenario for collagen dressings to support market 115 6.2.7 HYDROFIBER DRESSINGS 118 6.2.7.1 Combination of properties of hydrocolloids and alginates to boost adoption of hydrofiber dressings 118   6.2.8 WOUND CONTACT LAYERS 121 6.2.8.1 Ability to protect wound beds from bacterial and fungal growth to drive growth 121 6.2.9 SUPERABSORBENT DRESSINGS 123 6.2.9.1 Use of superabsorbent dressings for fragile skin to promote growth 123 6.2.10 OTHER ADVANCED DRESSINGS 126 6.3 DEVICES & ACCESSORIES 130 6.3.1 NPWT DEVICES & ACCESSORIES 132 6.3.1.1 Growing adoption of single-use NPWT devices in home care to drive growth 132 6.3.2 DEBRIDEMENT DEVICES & ACCESSORIES 135 6.3.2.1 Development of novel technologies to drive market 135 6.3.3 WOUND ASSESSMENT & MONITORING DEVICES 138 6.3.3.1 Potential cost-reducing capabilities of wound assessment & monitoring devices to boost adoption 138 6.3.4 OTHER DEVICES & ACCESSORIES 141 6.4 BIOLOGICAL SKIN SUBSTITUTES 144 6.4.1 HUMAN DONOR TISSUE-DERIVED PRODUCTS 148 6.4.1.1 High efficacy of human donor tissue-derived products to support market demand 148 6.4.2 ACELLULAR ANIMAL-DERIVED PRODUCTS 149 6.4.2.1 Recognition of importance of ECM in wound treatment to drive development of acellular wound care biologics 149 6.4.3 BIOSYNTHETIC PRODUCTS 150 6.4.3.1 Increased bioburden of infected wounds to drive development of biosynthetic wound care products 150 6.5 TOPICAL AGENTS 151 6.5.1 COST-EFFECTIVENESS AND EASE OF USE IN HOME CARE SETTINGS TO DRIVE DEMAND 151 7 ADVANCED WOUND CARE MARKET, BY WOUND TYPE 155 7.1 INTRODUCTION 156 7.2 SURGICAL & TRAUMATIC WOUNDS 156 7.2.1 RISING VOLUME OF SURGICAL PROCEDURES TO DRIVE MARKET 156 7.3 DIABETIC FOOT ULCERS 160 7.3.1 RISING DIABETES INCIDENCE TO DRIVE MARKET 160 7.4 PRESSURE ULCERS 164 7.4.1 GROWING GERIATRIC POPULATION TO DRIVE MARKET 164 7.5 VENOUS LEG ULCERS 167 7.5.1 RISING PREVALENCE OF OBESITY TO DRIVE MARKET 167 7.6 BURNS & OTHER WOUNDS 170 7.6.1 HIGH INCIDENCE OF BURN INJURIES IN DEVELOPING REGIONS TO SUPPORT MARKET GROWTH 170   8 ADVANCED WOUND CARE MARKET, BY END USER 174 8.1 INTRODUCTION 175 8.2 HOSPITALS, ASCS, AND WOUND CARE CENTERS 175 8.2.1 INCREASING NUMBER OF HOSPITALS AND GOVERNMENT INVESTMENTS TO DRIVE GROWTH 175 8.3 HOME CARE SETTINGS 179 8.3.1 DECREASED COSTS AND HIGHER CONVENIENCE AND COMFORT OF HOME CARE TO ENSURE MARKET GROWTH 179 8.4 OTHER END USERS 182 9 ADVANCED WOUND CARE MARKET, BY REGION 186 9.1 INTRODUCTION 187 9.2 NORTH AMERICA 187 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 188 9.2.2 US 192 9.2.2.1 Rising diabetes prevalence and supportive reimbursement policies to drive market 192 9.2.3 CANADA 195 9.2.3.1 Government-backed efforts supporting market development 195 9.3 EUROPE 198 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 199 9.3.2 GERMANY 203 9.3.2.1 Germany sees rising diabetes cases and chronic wound burden 203 9.3.3 UK 206 9.3.3.1 Increase in R&D activity to drive market 206 9.3.4 FRANCE 209 9.3.4.1 Rising chronic wound cases to drive market expansion 209 9.3.5 ITALY 212 9.3.5.1 Emerging market for advanced wound care in Europe 212 9.3.6 SPAIN 215 9.3.6.1 Rising life expectancy and aging population to drive demand 215 9.3.7 RUSSIA 218 9.3.7.1 Government initiatives to raise diabetes awareness to support market expansion 218 9.3.8 REST OF EUROPE 221 9.4 ASIA PACIFIC 224 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 225 9.4.2 CHINA 230 9.4.2.1 Increasing incidence of diabetic foot ulcers (DFUs) to drive growth 230 9.4.3 JAPAN 233 9.4.3.1 Evolving healthcare delivery and infrastructure landscape to fuel market 233   9.4.4 INDIA 236 9.4.4.1 Booming medical tourism to speed up growth 236 9.4.5 AUSTRALIA 239 9.4.5.1 Growing medical manufacturing companies to drive market 239 9.4.6 SOUTH KOREA 242 9.4.6.1 Increasing healthcare spending to sustain growth 242 9.4.7 SINGAPORE 245 9.4.7.1 Increasing awareness and focus on advanced wound care therapies to facilitate growth 245 9.4.8 REST OF ASIA PACIFIC 248 9.5 LATIN AMERICA 252 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 253 9.5.2 BRAZIL 256 9.5.2.1 Largest healthcare sector to drive market 256 9.5.3 MEXICO 259 9.5.3.1 Expanding hospital infrastructure to aid growth 259 9.5.4 REST OF LATIN AMERICA 262 9.6 MIDDLE EAST & AFRICA 265 9.6.1 GROWING DEMAND FOR HEALTHCARE FACILITIES TO DRIVE MARKET 265 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 266 10 COMPETITIVE LANDSCAPE 270 10.1 OVERVIEW 270 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2024 270 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ADVANCED WOUND CARE MARKET 270 10.3 REVENUE ANALYSIS, 2022–2024 272 10.4 MARKET SHARE ANALYSIS, 2024 272 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 275 10.5.1 STARS 276 10.5.2 EMERGING LEADERS 276 10.5.3 PERVASIVE PLAYERS 276 10.5.4 PARTICIPANTS 276 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 278 10.5.5.1 Company footprint 278 10.5.5.2 Region footprint 279 10.5.5.3 Product footprint 280 10.5.5.4 Wound type footprint 281 10.5.5.5 End user footprint 282   10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 283 10.6.1 PROGRESSIVE COMPANIES 283 10.6.2 RESPONSIVE COMPANIES 283 10.6.3 DYNAMIC COMPANIES 283 10.6.4 STARTING BLOCKS 283 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 285 10.6.5.1 Detailed list of key startups/SMEs 285 10.6.5.2 Competitive benchmarking of key startups/SMEs 285 10.7 COMPANY VALUATION AND FINANCIAL METRICS 286 10.7.1 COMPANY VALUATION 286 10.7.2 FINANCIAL METRICS 286 10.8 BRAND/PRODUCT COMPARISON 287 10.9 COMPETITIVE SCENARIO 287 10.9.1 PRODUCT LAUNCHES AND APPROVALS 287 10.9.2 DEALS 289 10.9.3 EXPANSIONS 290 10.9.4 OTHER DEVELOPMENTS 291 11 COMPANY PROFILES 292 11.1 KEY PLAYERS 292 11.1.1 SOLVENTUM 292 11.1.1.1 Business overview 292 11.1.1.2 Products/Solutions/Services offered 293 11.1.1.3 Recent developments 296 11.1.1.3.1 Product launches & approvals 296 11.1.1.3.2 Other developments 296 11.1.1.4 MnM view 296 11.1.1.4.1 Right to win 296 11.1.1.4.2 Strategic choices 296 11.1.1.4.3 Weaknesses & competitive threats 297 11.1.2 SMITH+NEPHEW 298 11.1.2.1 Business overview 298 11.1.2.2 Products/Solutions/Services offered 299 11.1.2.3 Recent developments 301 11.1.2.3.1 Product launches & approvals 301 11.1.2.3.2 Deals 302 11.1.2.3.3 Expansions 302 11.1.2.3.4 Other developments 302 11.1.2.4 MnM view 303 11.1.2.4.1 Right to win 303 11.1.2.4.2 Strategic choices 303 11.1.2.4.3 Weaknesses & competitive threats 303 11.1.3 MÖLNLYCKE AB 304 11.1.3.1 Business overview 304 11.1.3.2 Products/Solutions/Services offered 305 11.1.3.3 Recent developments 307 11.1.3.3.1 Deals 307 11.1.3.3.2 Other developments 308 11.1.3.4 MnM view 308 11.1.3.4.1 Right to win 308 11.1.3.4.2 Strategic choices 308 11.1.3.4.3 Weaknesses & competitive threats 308 11.1.4 CONVATEC GROUP PLC 309 11.1.4.1 Business overview 309 11.1.4.2 Products/Solutions/Services offered 310 11.1.4.3 Recent developments 311 11.1.4.3.1 Product launches & approvals 311 11.1.4.3.2 Deals 312 11.1.4.4 MnM view 312 11.1.4.4.1 Right to win 312 11.1.4.4.2 Strategic choices 312 11.1.4.4.3 Weaknesses & competitive threats 312 11.1.5 COLOPLAST GROUP 313 11.1.5.1 Business overview 313 11.1.5.2 Products/Solutions/Services offered 314 11.1.5.3 Recent developments 316 11.1.5.3.1 Product launches & approvals 316 11.1.5.3.2 Deals 316 11.1.5.4 MnM view 317 11.1.5.4.1 Right to win 317 11.1.5.4.2 Strategic choices 317 11.1.5.4.3 Weaknesses & competitive threats 317 11.1.6 ORGANOGENESIS INC. 318 11.1.6.1 Business overview 318 11.1.6.2 Products/Solutions/Services offered 319 11.1.6.3 Recent developments 319 11.1.6.3.1 Product launches & approvals 319 11.1.6.3.2 Expansions 319 11.1.7 PAUL HARTMANN AG 320 11.1.7.1 Business overview 320 11.1.7.2 Products/Solutions/Services offered 321 11.1.7.3 Recent developments 323 11.1.7.3.1 Deals 323   11.1.8 CARDINAL HEALTH 324 11.1.8.1 Business overview 324 11.1.8.2 Products/Solutions/Services offered 325 11.1.8.3 Recent developments 328 11.1.8.3.1 Deals 328 11.1.8.3.2 Expansions 328 11.1.9 MIMEDX GROUP, INC. 329 11.1.9.1 Business overview 329 11.1.9.2 Products/Solutions/Services offered 330 11.1.9.3 Recent developments 330 11.1.9.3.1 Product launches & approvals 330 11.1.10 OWENS & MINOR 331 11.1.10.1 Business overview 331 11.1.10.2 Products/Solutions/Services offered 332 11.1.10.3 Recent developments 332 11.1.10.3.1 Deals 332 11.1.10.3.2 Other developments 333 11.1.11 B. BRAUN SE 334 11.1.11.1 Business overview 334 11.1.11.2 Products/Solutions/Services offered 335 11.1.11.3 Recent developments 336 11.1.11.3.1 Expansions 336 11.1.11.3.2 Other developments 336 11.1.12 ESSITY AKTIEBOLAG 337 11.1.12.1 Business overview 337 11.1.12.2 Products/Solutions/Services offered 338 11.1.12.3 Recent developments 340 11.1.12.3.1 Other developments 340 11.1.13 INTEGRA LIFESCIENCES CORPORATION 341 11.1.13.1 Business overview 341 11.1.13.2 Products/Solutions/Services offered 342 11.1.13.3 Recent developments 343 11.1.13.3.1 Product launches & approvals 343 11.1.13.3.2 Other developments 344 11.1.14 AVERY DENNISON CORPORATION 345 11.1.14.1 Business overview 345 11.1.14.2 Products/Solutions/Services offered 346 11.1.14.3 Recent developments 347 11.1.14.3.1 Expansions 347   11.1.15 MATIV HOLDINGS, INC. 348 11.1.15.1 Business overview 348 11.1.15.2 Products/Solutions/Services offered 349 11.1.15.3 Recent developments 350 11.1.15.3.1 Deals 350 11.1.16 BIOVENTUS 351 11.1.16.1 Business overview 351 11.1.16.2 Products/Solutions/Services offered 352 11.1.16.3 Recent developments 353 11.1.16.3.1 Deals 353 11.1.16.3.2 Other developments 353 11.1.17 ZIMMER BIOMET 354 11.1.17.1 Business overview 354 11.1.17.2 Products/Solutions/Services offered 355 11.1.17.3 Recent developments 356 11.1.17.3.1 Deals 356 11.2 OTHER PLAYERS 357 11.2.1 LOHMANN & RAUSCHER GMBH & CO. KG 357 11.2.2 MEDLINE INDUSTRIES, LP 358 11.2.3 DEROYAL INDUSTRIES, INC. 359 11.2.4 WINNER MEDICAL CO., LTD. 360 11.2.5 ADVANCIS (UK) 361 11.2.6 MIL LABORATORIES PVT. LTD. 362 11.2.7 PENSAR MEDICAL 363 11.2.8 HAROMED BV 364 11.2.9 URGO GROUP 365 11.2.10 DIRECT HEALTHCARE GROUP 365 11.2.11 DERMARITE INDUSTRIES, LLC. 366 11.2.12 MEDAXIS LLC 367 11.2.13 GENTELL 368 12 APPENDIX 369 12.1 DISCUSSION GUIDE 369 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 372 12.3 CUSTOMIZATION OPTIONS 374 12.4 RELATED REPORTS 374 12.5 AUTHOR DETAILS 375

TABLE 1 ADVANCED WOUND CARE MARKET: INCLUSIONS AND EXCLUSIONS 35 TABLE 2 ADVANCED WOUND CARE WOUND CARE MARKET: RISK ASSESSMENT 48 TABLE 3 POPULATION AGES 65 AND ABOVE (% OF TOTAL POPULATION), 2023 57 TABLE 4 ROAD ACCIDENT DEMOGRAPHIC, 2022 58 TABLE 5 CHINA: STATES ON DISCHARGE OF PATIENTS WITH TYPE 2 DFU IN DIFFERENT AGE GROUPS, JANUARY 2017–DECEMBER 2023 59 TABLE 6 RISKS ASSOCIATED WITH ADVANCED WOUND CARE PRODUCTS 62 TABLE 7 STRATEGIC DEVELOPMENTS IN ASIA PACIFIC, 2023–2024 62 TABLE 8 AVERAGE SELLING PRICING TREND OF ADVANCED WOUND CARE PRODUCTS, 2023–2025 65 TABLE 9 AVERAGE SELLING PRICE TREND AMONG KEY PLAYERS, BY WOUND TYPE, 2023–2025 65 TABLE 10 AVERAGE SELLING PRICE TREND KEY PLAYERS, BY REGION, 2023–2025 66 TABLE 11 ADVANCED WOUND CARE MARKET: ROLE OF COMPANIES IN ECOSYSTEM 69 TABLE 12 ADVANCED WOUND CARE MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2023–2025 73 TABLE 13 IMPORT DATA (HS CODE 300510), BY COUNTRY, 2020–2024 (USD MILLION) 74 TABLE 14 EXPORT DATA (HS CODE 300510), BY COUNTRY, 2020–2024 (USD MILLION) 74 TABLE 15 ADVANCED WOUND CARE MARKET: KEY CONFERENCES AND EVENTS, APRIL 2025–DECEMBER 2026 75 TABLE 16 TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN 80 TABLE 17 NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81 TABLE 18 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81 TABLE 19 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 81 TABLE 20 LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82 TABLE 21 REST OF THE WORLD: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 82 TABLE 22 ADVANCED WOUND CARE MARKET: PORTER’S FIVE FORCES ANALYSIS 83 TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ADVANCED WOUND CARE PRODUCTS (%) 85 TABLE 24 KEY BUYING CRITERIA FOR ADVANCED WOUND CARE PRODUCTS 86 TABLE 25 US ADJUSTED RECIPROCAL TARIFF RATES 89 TABLE 26 ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 93 TABLE 27 ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 94 TABLE 28 ADVANCED WOUND CARE DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 94 TABLE 29 NORTH AMERICA: ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 95 TABLE 30 EUROPE: ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 95 TABLE 31 ASIA PACIFIC: ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 96 TABLE 32 LATIN AMERICA: ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 96 TABLE 33 KEY PRODUCTS IN FOAM DRESSINGS MARKET 97 TABLE 34 FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 98 TABLE 35 FOAM DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 98 TABLE 36 NORTH AMERICA: FOAM DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 98 TABLE 37 EUROPE: FOAM DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99 TABLE 38 ASIA PACIFIC: FOAM DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 99 TABLE 39 LATIN AMERICA: FOAM DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 100 TABLE 40 SILICONE DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 100 TABLE 41 NORTH AMERICA: SILICONE DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 101 TABLE 42 EUROPE: SILICONE DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 101 TABLE 43 ASIA PACIFIC: SILICONE DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 102 TABLE 44 LATIN AMERICA: SILICONE DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 102 TABLE 45 NON-SILICONE DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 103 TABLE 46 NORTH AMERICA: NON-SILICONE DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 103 TABLE 47 EUROPE: NON-SILICONE DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 104 TABLE 48 ASIA PACIFIC: NON-SILICONE DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 104 TABLE 49 LATIN AMERICA: NON-SILICONE DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 105 TABLE 50 KEY PRODUCTS IN HYDROCOLLOID DRESSINGS MARKET 105 TABLE 51 HYDROCOLLOID DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 106 TABLE 52 NORTH AMERICA: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 53 EUROPE: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 54 ASIA PACIFIC: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 107 TABLE 55 LATIN AMERICA: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 108 TABLE 56 KEY PRODUCTS IN FILM DRESSINGS MARKET 108 TABLE 57 FILM DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 109 TABLE 58 NORTH AMERICA: FILM DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 59 EUROPE: FILM DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 60 ASIA PACIFIC: FILM DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 61 LATIN AMERICA: FILM DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 110 TABLE 62 KEY PRODUCTS IN ALGINATE DRESSINGS MARKET 111 TABLE 63 ALGINATE DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 111 TABLE 64 NORTH AMERICA: ALGINATE DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 111 TABLE 65 EUROPE: ALGINATE DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 66 ASIA PACIFIC: ALGINATE DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 67 LATIN AMERICA: ALGINATE DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 113 TABLE 68 KEY PRODUCTS IN HYDROGEL DRESSINGS MARKET 113 TABLE 69 HYDROGEL DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 114 TABLE 70 NORTH AMERICA: HYDROGEL DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 71 EUROPE: HYDROGEL DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 114 TABLE 72 ASIA PACIFIC: HYDROGEL DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 73 LATIN AMERICA: HYDROGEL DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 74 KEY PRODUCTS IN COLLAGEN DRESSINGS MARKET 116 TABLE 75 COLLAGEN DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 116 TABLE 76 NORTH AMERICA: COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 77 EUROPE: COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 78 ASIA PACIFIC: COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 79 LATIN AMERICA: COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 118 TABLE 80 KEY PRODUCTS IN HYDROFIBER DRESSINGS MARKET 119 TABLE 81 HYDROFIBER DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 119 TABLE 82 NORTH AMERICA: HYDROFIBER DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 119 TABLE 83 EUROPE: HYDROFIBER DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 84 ASIA PACIFIC: HYDROFIBER DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 85 LATIN AMERICA: HYDROFIBER DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 121 TABLE 86 KEY PRODUCTS IN WOUND CONTACT LAYERS MARKET 121 TABLE 87 WOUND CONTACT LAYERS MARKET, BY REGION, 2023–2030 (USD MILLION) 122 TABLE 88 NORTH AMERICA: WOUND CONTACT LAYERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 89 EUROPE: WOUND CONTACT LAYERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 122 TABLE 90 ASIA PACIFIC: WOUND CONTACT LAYERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 91 LATIN AMERICA: WOUND CONTACT LAYERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 92 KEY PRODUCTS IN SUPERABSORBENT DRESSINGS MARKET 124 TABLE 93 SUPERABSORBENT DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 124 TABLE 94 NORTH AMERICA: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 95 EUROPE: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 125 TABLE 96 ASIA PACIFIC: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 97 LATIN AMERICA: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 98 KEY PRODUCTS IN OTHER ADVANCED DRESSINGS MARKET 127 TABLE 99 OTHER ADVANCED DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 128 TABLE 100 NORTH AMERICA: OTHER ADVANCED DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 101 EUROPE: OTHER ADVANCED DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128 TABLE 102 ASIA PACIFIC: OTHER ADVANCED DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 103 LATIN AMERICA: OTHER ADVANCED DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 104 ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 130 TABLE 105 DEVICES & ACCESSORIES MARKET, BY REGION, 2023–2030 (USD MILLION) 130 TABLE 106 NORTH AMERICA: DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 107 EUROPE: DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 131 TABLE 108 ASIA PACIFIC: DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 132 TABLE 109 LATIN AMERICA: DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 132 TABLE 110 KEY PRODUCTS IN NPWT DEVICES & ACCESSORIES MARKET 133 TABLE 111 NPWT DEVICES & ACCESSORIES MARKET, BY REGION, 2023–2030 (USD MILLION) 134 TABLE 112 NORTH AMERICA: NPWT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 113 EUROPE: NPWT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 114 ASIA PACIFIC: NPWT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 115 LATIN AMERICA: NPWT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135 TABLE 116 KEY PRODUCTS IN DEBRIDEMENT DEVICES & ACCESSORIES MARKET 136 TABLE 117 DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY REGION, 2023–2030 (USD MILLION) 136 TABLE 118 NORTH AMERICA: DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 119 EUROPE: DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 120 ASIA PACIFIC: DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 121 LATIN AMERICA: DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 138 TABLE 122 KEY PRODUCTS IN WOUND ASSESSMENT & MONITORING DEVICES MARKET 139 TABLE 123 WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 139 TABLE 124 NORTH AMERICA: WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 139 TABLE 125 EUROPE: WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 126 ASIA PACIFIC: WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 127 LATIN AMERICA: WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 141 TABLE 128 KEY PRODUCTS IN OTHER DEVICES & ACCESSORIES MARKET 142 TABLE 129 OTHER DEVICES & ACCESSORIES MARKET, BY REGION, 2023–2030 (USD MILLION) 143 TABLE 130 NORTH AMERICA: OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 131 EUROPE: OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 132 ASIA PACIFIC: OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 133 LATIN AMERICA: OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 144 TABLE 134 KEY PRODUCTS IN BIOLOGICAL SKIN SUBSTITUTES MARKET 145 TABLE 135 BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2023–2030 (USD MILLION) 145 TABLE 136 BIOLOGICAL SKIN SUBSTITUTES MARKET, BY REGION, 2023–2030 (USD MILLION) 146 TABLE 137 NORTH AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 138 EUROPE: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 139 ASIA PACIFIC: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 147 TABLE 140 LATIN AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 141 KEY PRODUCTS IN HUMAN DONOR TISSUE MARKET 148 TABLE 142 HUMAN DONOR TISSUE MARKET, BY REGION, 2023–2030 (USD MILLION) 149 TABLE 143 KEY PRODUCTS IN ACELLULAR ANIMAL-DERIVED MARKET 149 TABLE 144 ACELLULAR ANIMAL-DERIVED MARKET, BY REGION, 2023–2030 (USD MILLION) 150 TABLE 145 KEY PRODUCTS IN BIOSYNTHETIC MARKET 150 TABLE 146 BIOSYNTHETIC PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 151 TABLE 147 KEY PRODUCTS IN TOPICAL AGENTS MARKET 152 TABLE 148 TOPICAL AGENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 152 TABLE 149 NORTH AMERICA: TOPICAL AGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 150 EUROPE: TOPICAL AGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 153 TABLE 151 ASIA PACIFIC: TOPICAL AGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 152 LATIN AMERICA: TOPICAL AGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 153 ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 156 TABLE 154 ADVANCED WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY REGION, 2023–2030 (USD MILLION) 158 TABLE 155 NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 158 TABLE 156 EUROPE: ADVANCED WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 157 ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 158 LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 160 TABLE 159 TOTAL DIABETES-RELATED HEALTHCARE EXPENDITURE IN 2024 (USD MILLION) 161 TABLE 160 NUMBER OF ADULT PATIENTS WITH DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (THOUSANDS) 161 TABLE 161 ADVANCED WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY REGION, 2023–2030 (USD MILLION) 162 TABLE 162 NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 162 TABLE 163 EUROPE: ADVANCED WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 164 ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 165 LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 164 TABLE 166 ADVANCED WOUND CARE MARKET FOR PRESSURE ULCERS, BY REGION, 2023–2030 (USD MILLION) 165 TABLE 167 NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 165 TABLE 168 EUROPE: ADVANCED WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 169 ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 170 LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 167 TABLE 171 ADVANCED WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY REGION, 2023–2030 (USD MILLION) 168 TABLE 172 NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 173 EUROPE ADVANCED WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 174 ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 169 TABLE 175 LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 170 TABLE 176 ADVANCED WOUND CARE MARKET FOR BURNS & OTHER WOUNDS, BY REGION, 2023–2030 (USD MILLION) 171 TABLE 177 NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR BURNS & OTHER WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 178 EUROPE: ADVANCED WOUND CARE MARKET FOR BURNS & OTHER WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 179 ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR BURNS & OTHER WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 172 TABLE 180 LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR BURNS & OTHER WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 173 TABLE 181 ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 175 TABLE 182 HOSPITALS PER CAPITA, BY COUNTRY, 2024 177 TABLE 183 ADVANCED WOUND CARE MARKET FOR HOSPITALS, ASCS, AND WOUND CARE CENTERS, BY REGION, 2023–2030 (USD MILLION) 177 TABLE 184 NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR HOSPITALS, ASCS, AND WOUND CARE CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 185 EUROPE: ADVANCED WOUND CARE MARKET FOR HOSPITALS, ASCS, AND WOUND CARE CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 178 TABLE 186 ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR HOSPITALS, ASCS, AND WOUND CARE CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 187 LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR HOSPITALS, ASCS, AND WOUND CARE CENTERS, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 188 ADVANCED WOUND CARE MARKET FOR HOME CARE SETTINGS, BY REGION, 2023–2030 (USD MILLION) 180 TABLE 189 NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 190 EUROPE: ADVANCED WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 181 TABLE 191 ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 192 LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 193 ADVANCED WOUND CARE MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 183 TABLE 194 NORTH AMERICA: ADVANCED WOUND CARE MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 195 EUROPE: ADVANCED WOUND CARE MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 196 ASIA PACIFIC: ADVANCED WOUND CARE MARKET FOR OTHER END USERS, BY COUNTRY, 2023–2030 (USD MILLION) 185 TABLE 197 LATIN AMERICA: ADVANCED WOUND CARE MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2030 (USD MILLION) 185 TABLE 198 ADVANCED WOUND CARE MARKET, BY REGION, 2023–2030 (USD MILLION) 187 TABLE 199 NORTH AMERICA: MACROECONOMIC INDICATORS 188 TABLE 200 NORTH AMERICA: ADVANCED WOUND CARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 201 NORTH AMERICA: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 190 TABLE 202 NORTH AMERICA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 190 TABLE 203 NORTH AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 204 NORTH AMERICA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 191 TABLE 205 NORTH AMERICA: ADVANCED WOUND CARE DRESSINGS MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 191 TABLE 206 NORTH AMERICA: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 192 TABLE 207 US: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 193 TABLE 208 US: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 193 TABLE 209 US: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 210 US: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 194 TABLE 211 US: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 194 TABLE 212 US: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 195 TABLE 213 ESTIMATED PREVALENCE AND COST OF DIABETES 195 TABLE 214 CANADA: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 196 TABLE 215 CANADA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 216 CANADA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 217 CANADA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 197 TABLE 218 CANADA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 198 TABLE 219 CANADA: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 198 TABLE 220 EUROPE: MACROECONOMIC INDICATORS 199 TABLE 221 EUROPE: ADVANCED WOUND CARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 200 TABLE 222 EUROPE: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 200 TABLE 223 EUROPE: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 224 EUROPE: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 201 TABLE 225 EUROPE: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 202 TABLE 226 EUROPE: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 202 TABLE 227 EUROPE: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 203 TABLE 228 GERMANY: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 204 TABLE 229 GERMANY: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 204 TABLE 230 GERMANY: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 231 GERMANY: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 205 TABLE 232 GERMANY: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 205 TABLE 233 GERMANY: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 206 TABLE 234 UK: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 207 TABLE 235 UK: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 207 TABLE 236 UK: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 237 UK: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 208 TABLE 238 UK: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 208 TABLE 239 UK: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 209 TABLE 240 FRANCE: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 209 TABLE 241 FRANCE: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 242 FRANCE: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 210 TABLE 243 FRANCE: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 211 TABLE 244 FRANCE: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 211 TABLE 245 FRANCE: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 212 TABLE 246 ITALY: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 213 TABLE 247 ITALY: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 213 TABLE 248 ITALY: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 249 ITALY: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 214 TABLE 250 ITALY: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 214 TABLE 251 ITALY: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 215 TABLE 252 SPAIN: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 216 TABLE 253 SPAIN: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030(USD MILLION) 216 TABLE 254 SPAIN: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 255 SPAIN: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 217 TABLE 256 SPAIN: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 217 TABLE 257 SPAIN: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 218 TABLE 258 RUSSIA: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 219 TABLE 259 RUSSIA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 219 TABLE 260 RUSSIA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 261 RUSSIA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 220 TABLE 262 RUSSIA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 220 TABLE 263 RUSSIA: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 221 TABLE 264 REST OF EUROPE: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 222 TABLE 265 REST OF EUROPE: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 266 REST OF EUROPE: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 267 REST OF EUROPE: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 223 TABLE 268 REST OF EUROPE: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 224 TABLE 269 REST OF EUROPE: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 224 TABLE 270 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS 225 TABLE 271 ASIA PACIFIC: ADVANCED WOUND CARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 227 TABLE 272 ASIA PACIFIC: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 227 TABLE 273 ASIA PACIFIC: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 274 ASIA PACIFIC: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 228 TABLE 275 ASIA PACIFIC: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 229 TABLE 276 ASIA PACIFIC: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 229 TABLE 277 ASIA PACIFIC: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 230 TABLE 278 CHINA: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 231 TABLE 279 CHINA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 231 TABLE 280 CHINA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 281 CHINA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 232 TABLE 282 CHINA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 233 TABLE 283 CHINA: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 233 TABLE 284 JAPAN: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 234 TABLE 285 JAPAN: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 234 TABLE 286 JAPAN: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 287 JAPAN: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 235 TABLE 288 JAPAN: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 235 TABLE 289 JAPAN: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 236 TABLE 290 INDIA: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 237 TABLE 291 INDIA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 237 TABLE 292 INDIA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 238 TABLE 293 INDIA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 238 TABLE 294 INDIA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 239 TABLE 295 INDIA: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 239 TABLE 296 AUSTRALIA: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 240 TABLE 297 AUSTRALIA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 240 TABLE 298 AUSTRALIA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 299 AUSTRALIA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 241 TABLE 300 AUSTRALIA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 241 TABLE 301 AUSTRALIA: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 242 TABLE 302 SOUTH KOREA: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 243 TABLE 303 SOUTH KOREA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 243 TABLE 304 SOUTH KOREA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 305 SOUTH KOREA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 244 TABLE 306 SOUTH KOREA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 245 TABLE 307 SOUTH KOREA: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 245 TABLE 308 SINGAPORE: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 246 TABLE 309 SINGAPORE: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 246 TABLE 310 SINGAPORE: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 311 SINGAPORE: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 247 TABLE 312 SINGAPORE: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 248 TABLE 313 SINGAPORE: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 248 TABLE 314 REST OF ASIA PACIFIC: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 249 TABLE 315 REST OF ASIA PACIFIC: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 316 REST OF ASIA PACIFIC: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 250 TABLE 317 REST OF ASIA PACIFIC: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 251 TABLE 318 REST OF ASIA PACIFIC: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 251 TABLE 319 REST OF ASIA PACIFIC: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 252 TABLE 320 LATIN AMERICA: KEY MACROECONOMIC INDICATORS 253 TABLE 321 LATIN AMERICA: ADVANCED WOUND CARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 253 TABLE 322 LATIN AMERICA: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 254 TABLE 323 LATIN AMERICA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 254 TABLE 324 LATIN AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 325 LATIN AMERICA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 255 TABLE 326 LATIN AMERICA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 256 TABLE 327 LATIN AMERICA: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 256 TABLE 328 BRAZIL: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 257 TABLE 329 BRAZIL: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 257 TABLE 330 BRAZIL: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 331 BRAZIL: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 258 TABLE 332 BRAZIL: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 259 TABLE 333 BRAZIL: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 259 TABLE 334 MEXICO: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 260 TABLE 335 MEXICO: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 260 TABLE 336 MEXICO: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 337 MEXICO: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 261 TABLE 338 MEXICO: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 261 TABLE 339 MEXICO: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 262 TABLE 340 REST OF LATIN AMERICA: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 262 TABLE 341 REST OF LATIN AMERICA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 342 REST OF LATIN AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 263 TABLE 343 REST OF LATIN AMERICA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 264 TABLE 344 REST OF LATIN AMERICA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 264 TABLE 345 REST OF LATIN AMERICA: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 265 TABLE 346 MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS 266 TABLE 347 MIDDLE EAST & AFRICA: ADVANCED WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 266 TABLE 348 MIDDLE EAST & AFRICA: ADVANCED WOUND CARE DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 349 MIDDLE EAST & AFRICA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 267 TABLE 350 MIDDLE EAST & AFRICA: ADVANCED WOUND CARE DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 268 TABLE 351 MIDDLE EAST & AFRICA: ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 268 TABLE 352 MIDDLE EAST & AFRICA: ADVANCED WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 269 TABLE 353 ADVANCED WOUND CARE MARKET: OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES, JANUARY 2022–APRIL 2025 270 TABLE 354 ADVANCED WOUND CARE MARKET: DEGREE OF COMPETITION 273 TABLE 355 ADVANCED WOUND CARE MARKET: REGION FOOTPRINT 279 TABLE 356 ADVANCED WOUND CARE MARKET: PRODUCT FOOTPRINT 280 TABLE 357 ADVANCED WOUND CARE MARKET: WOUND TYPE FOOTPRINT 281 TABLE 358 ADVANCED WOUND CARE MARKET: END USER FOOTPRINT 282 TABLE 359 ADVANCED WOUND CARE MARKET: DETAILED LIST OF KEY STARTUPS/SMES 285 TABLE 360 ADVANCED WOUND CARE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 285 TABLE 361 ADVANCED WOUND CARE MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2022–APRIL 2025 288 TABLE 362 ADVANCED WOUND CARE MARKET: DEALS, JANUARY 2022–APRIL 2025 289 TABLE 363 ADVANCED WOUND CARE MARKET: EXPANSIONS, JANUARY 2022–APRIL 2025 290 TABLE 364 ADVANCED WOUND CARE MARKET: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025 291 TABLE 365 SOLVENTUM: COMPANY OVERVIEW 292 TABLE 366 SOLVENTUM: PRODUCTS/SOLUTIONS/SERVICES OFFERED 293 TABLE 367 SOLVENTUM: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–APRIL 2025 296 TABLE 368 SOLVENTUM: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025 296 TABLE 369 SMITH+NEPHEW: COMPANY OVERVIEW 298 TABLE 370 SMITH+NEPHEW: PRODUCTS/SOLUTIONS/SERVICES OFFERED 299 TABLE 371 SMITH+NEPHEW: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–APRIL 2025 301 TABLE 372 SMITH+NEPHEW: DEALS, JANUARY 2022–APRIL 2025 302 TABLE 373 SMITH+NEPHEW: EXPANSIONS, JANUARY 2022–APRIL 2025 302 TABLE 374 SMITH+NEPHEW: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025 302 TABLE 375 MÖLNLYCKE AB: COMPANY OVERVIEW 304 TABLE 376 MÖLNLYCKE AB: PRODUCTS/SOLUTIONS/SERVICES OFFERED 305 TABLE 377 MÖLNLYCKE AB: DEALS, JANUARY 2022–APRIL 2025 307 TABLE 378 MÖLNLYCKE AB: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025 308 TABLE 379 CONVATEC GROUP PLC: COMPANY OVERVIEW 309 TABLE 380 CONVATEC GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED 310 TABLE 381 CONVATEC GROUP PLC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–APRIL 2025 311 TABLE 382 CONVATEC GROUP PLC: DEALS, JANUARY 2022–APRIL 2025 312 TABLE 383 COLOPLAST GROUP: COMPANY OVERVIEW 313 TABLE 384 COLOPLAST GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED 314 TABLE 385 COLOPLAST GROUP: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–APRIL 2025 316 TABLE 386 COLOPLAST GROUP: DEALS, JANUARY 2022–APRIL 2025 316 TABLE 387 ORGANOGENESIS INC.: COMPANY OVERVIEW 318 TABLE 388 ORGANOGENESIS INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 319 TABLE 389 ORGANOGENESIS INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–APRIL 2025 319 TABLE 390 ORGANOGENESIS INC.: EXPANSIONS, JANUARY 2022–APRIL 2025 319 TABLE 391 PAUL HARTMANN AG: COMPANY OVERVIEW 320 TABLE 392 PAUL HARTMANN AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 321 TABLE 393 PAUL HARTMANN AG: DEALS, JANUARY 2022–APRIL 2025 323 TABLE 394 CARDINAL HEALTH: COMPANY OVERVIEW 324 TABLE 395 CARDINAL HEALTH: PRODUCTS/SOLUTIONS/SERVICES OFFERED 325 TABLE 396 CARDINAL HEALTH: DEALS, JANUARY 2022–APRIL 2025 328 TABLE 397 CARDINAL HEALTH: EXPANSIONS, JANUARY 2022–APRIL 2025 328 TABLE 398 MIMEDX GROUP, INC.: COMPANY OVERVIEW 329 TABLE 399 MIMEDX GROUP, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 330 TABLE 400 MIMEDX GROUP, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–APRIL 2025 330 TABLE 401 OWENS & MINOR: COMPANY OVERVIEW 331 TABLE 402 OWENS & MINOR: PRODUCTS/SOLUTIONS/SERVICES OFFERED 332 TABLE 403 OWENS & MINOR: DEALS, JANUARY 2022–JANUARY 2025 332 TABLE 404 OWENS & MINOR: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025 333 TABLE 405 B. BRAUN SE: COMPANY OVERVIEW 334 TABLE 406 B. BRAUN SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED 335 TABLE 407 B. BRAUN SE: EXPANSIONS, JANUARY 2022–APRIL 2025 336 TABLE 408 B. BRAUN SE: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025 336 TABLE 409 ESSITY AKTIEBOLAG: COMPANY OVERVIEW 337 TABLE 410 ESSITY AKTIEBOLAG: PRODUCTS/SOLUTIONS/SERVICES OFFERED 338 TABLE 411 ESSITY AKTIEBOLAG: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025 340 TABLE 412 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW 341 TABLE 413 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 342 TABLE 414 INTEGRA LIFESCIENCES CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–APRIL 2025 343 TABLE 415 INTEGRA LIFESCIENCES CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025 344 TABLE 416 AVERY DENNISON CORPORATION: COMPANY OVERVIEW 345 TABLE 417 AVERY DENNISON CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED 346 TABLE 418 AVERY DENNISON CORPORATION: EXPANSIONS, JANUARY 2022–APRIL 2025 347 TABLE 419 MATIV HOLDINGS, INC.: COMPANY OVERVIEW 348 TABLE 420 MATIV HOLDINGS, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 349 TABLE 421 MATIV HOLDINGS, INC.: DEALS, JANUARY 2022–APRIL 2025 350 TABLE 422 BIOVENTUS: COMPANY OVERVIEW 351 TABLE 423 BIOVENTUS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 352 TABLE 424 BIOVENTUS: DEALS, JANUARY 2022–JANUARY 2025 353 TABLE 425 BIOVENTUS: OTHER DEVELOPMENTS, JANUARY 2022–APRIL 2025 353 TABLE 426 ZIMMER BIOMET: COMPANY OVERVIEW 354 TABLE 427 ZIMMER BIOMET: PRODUCTS/SOLUTIONS/SERVICES OFFERED 355 TABLE 428 ZIMMER BIOMET: DEALS, JANUARY 2022–APRIL 2025 356 TABLE 429 LOHMANN & RAUSCHER GMBH & CO. KG: COMPANY OVERVIEW 357 TABLE 430 MEDLINE INDUSTRIES, LP: COMPANY OVERVIEW 358 TABLE 431 DEROYAL INDUSTRIES, INC.: COMPANY OVERVIEW 359 TABLE 432 WINNER MEDICAL CO., LTD.: COMPANY OVERVIEW 360 TABLE 433 ADVANCIS (UK): COMPANY OVERVIEW 361 TABLE 434 MIL LABORATORIES PVT. LTD.: COMPANY OVERVIEW 362 TABLE 435 PENSAR MEDICAL: COMPANY OVERVIEW 363 TABLE 436 HAROMED BV: COMPANY OVERVIEW 364 TABLE 437 URGO GROUP: COMPANY OVERVIEW 365 TABLE 438 DIRECT HEALTHCARE GROUP: COMPANY OVERVIEW 365 TABLE 439 DERMARITE INDUSTRIES, LLC.: COMPANY OVERVIEW 366 TABLE 440 GENTELL: COMPANY OVERVIEW 368 FIGURE 1 ADVANCED WOUND CARE MARKET SEGMENTATION AND REGIONAL SCOPE 34 FIGURE 2 ADVANCED WOUND CARE MARKET: RESEARCH DESIGN 38 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 42 FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 43 FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 44 FIGURE 6 ADVANCED WOUND CARE MARKET: TOP-DOWN APPROACH 45 FIGURE 7 DATA TRIANGULATION METHODOLOGY 46 FIGURE 8 ADVANCED WOUND CARE MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 49 FIGURE 9 ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2025 VS. 2030 (USD MILLION) 50 FIGURE 10 ADVANCED WOUND CARE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 50 FIGURE 11 GEOGRAPHICAL SNAPSHOT OF ADVANCED WOUND CARE MARKET 51 FIGURE 12 INCREASING PREVALENCE OF DIABETES AND GROWING GERIATRIC POPULATION TO DRIVE MARKET 53 FIGURE 13 HOSPITALS, ASCS, AND WOUND CARE CENTERS ACCOUNTED FOR LARGEST SHARE IN 2024 54 FIGURE 14 INDIA TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030 55 FIGURE 15 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 55 FIGURE 16 ADVANCED WOUND CARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 56 FIGURE 17 ADVANCED WOUND CARE MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 64 FIGURE 18 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES 67 FIGURE 19 ADVANCED WOUND CARE MARKET: SUPPLY CHAIN ANALYSIS 68 FIGURE 20 ADVANCED WOUND CARE MARKET: ECOSYSTEM ANALYSIS 69 FIGURE 21 ADVANCED WOUND CARE MARKET: INVESTMENT AND FUNDING SCENARIO, 2019–2025 70 FIGURE 22 ADVANCED WOUND CARE MARKET: PATENT ANALYSIS, JANUARY 2015–DECEMBER 2024 72 FIGURE 23 ADVANCED WOUND CARE MARKET: PORTER’S FIVE FORCES ANALYSIS 83 FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ADVANCED WOUND CARE PRODUCTS 85 FIGURE 25 KEY BUYING CRITERIA FOR ADVANCED WOUND CARE PRODUCTS 85 FIGURE 26 AI USE CASES 87 FIGURE 27 NORTH AMERICA: ADVANCED WOUND CARE MARKET SNAPSHOT 189 FIGURE 28 ASIA PACIFIC: ADVANCED WOUND CARE MARKET SNAPSHOT 226 FIGURE 29 ADVANCED WOUND CARE MARKET: REVENUE ANALYSIS OF KEY PLAYERS, 2022–2024 272 FIGURE 30 ADVANCED WOUND CARE MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 273 FIGURE 31 NEGATIVE PRESSURE WOUND THERAPY MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 274 FIGURE 32 ADVANCED WOUND DRESSINGS MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 275 FIGURE 33 RANKING OF KEY PLAYERS IN ADVANCED WOUND CARE MARKET, 2024 275 FIGURE 34 ADVANCED WOUND CARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 277 FIGURE 35 ADVANCED WOUND CARE MARKET: COMPANY FOOTPRINT 278 FIGURE 36 ADVANCED WOUND CARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 284 FIGURE 37 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS 286 FIGURE 38 EV/EBITDA OF KEY VENDORS 286 FIGURE 39 ADVANCED WOUND CARE MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 287 FIGURE 40 SOLVENTUM: COMPANY SNAPSHOT (2024) 293 FIGURE 41 SMITH+NEPHEW: COMPANY SNAPSHOT (2024) 299 FIGURE 42 MÖLNLYCKE AB: COMPANY SNAPSHOT (2024) 305 FIGURE 43 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2024) 310 FIGURE 44 COLOPLAST GROUP: COMPANY SNAPSHOT (2024) 314 FIGURE 45 ORGANOGENESIS INC.: COMPANY SNAPSHOT (2024) 318 FIGURE 46 PAUL HARTMANN AG: COMPANY SNAPSHOT (2024) 321 FIGURE 47 CARDINAL HEALTH: COMPANY SNAPSHOT (2024) 325 FIGURE 48 MIMEDX GROUP, INC.: COMPANY SNAPSHOT (2024) 329 FIGURE 49 OWENS & MINOR: COMPANY SNAPSHOT (2024) 331 FIGURE 50 B. BRAUN SE: COMPANY SNAPSHOT (2024) 335 FIGURE 51 ESSITY AKTIEBOLAG: COMPANY SNAPSHOT (2024) 338 FIGURE 52 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2024) 342 FIGURE 53 AVERY DENNISON CORPORATION: COMPANY SNAPSHOT (2024) 346 FIGURE 54 MATIV HOLDINGS, INC.: COMPANY SNAPSHOT (2024) 349 FIGURE 55 BIOVENTUS: COMPANY SNAPSHOT (2024) 352 FIGURE 56 ZIMMER BIOMET: COMPANY SNAPSHOT (2024) 355